Jubbal Kevin T, Zavlin Dmitry, Suliman Ahmed
Department of Plastic Surgery, Loma Linda University Medical Center, Loma Linda, California.
Houston Methodist Hospital., Institute for Reconstructive Surgery, Houston, Texas.
Microsurgery. 2017 Nov;37(8):858-864. doi: 10.1002/micr.30189. Epub 2017 Jun 2.
The growing elderly population necessitates a greater number of aging patients requiring complex reconstructive surgery involving free tissue transfer. The purpose of this study was to assess the safety, efficacy, and outcomes of microsurgical free tissue transfer in elderly patients using a national multi-institutional database.
We performed a retrospective analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database to identify patients undergoing free tissue transfer. We stratified cohorts based on ages 18-49, 50-59, 60-69, 70-79, and 80+ years and analyzed primary outcomes of surgical complications, medical complications, mortality, and flap failure.
A total of 5,951 patients were identified for inclusion in the analysis. Univariate analysis demonstrated progressively increasing surgical (P = .001) and medical (P < .001) complication rates with increasing age. After controlling for confounding variables, age was not significantly associated with rates of surgical (OR 1.00, 95% CI 0.99-1.01, P = .737) or medical (OR 1.01, 95% CI 0.99-1.03, P = .209) complications, flap failure (OR 1.00, 95% CI 1.00-1.02, P = .689), or reoperation (OR 1.01, 95% CI 1.00-1.03, P = 0.165). Factors associated with surgical complications included BMI (OR 1.03, 95% CI 1.00-1.05, P = .031), prolonged operative time (OR 1.001, 95% CI 1.000-1.002, P = .002), American Society of Anesthesiologists (ASA) classification of 3 or greater (OR 1.62, 95% CI 1.17-2.23, P = .003), and prolonged hospitalization (OR 1.03, 95% CI 1.02-1.04, P < .001). ASA classification of 3 or greater (OR 2.57, 95% CI 1.48-4.45, P = .001), renal history (OR 10.13, 95% CI 1.57-65.55, P = .015), and prolonged hospitalization (OR 1.06, 95% CI 1.04-1.08, P < .001) were associated with medical complications. Age was associated with increased mortality (OR 1.06, 95% CI 1.00-1.13, P = .048).
Age alone should not be used as an absolute or even relative contraindication in patient assessment. Rather, preoperative assessment should focus on comorbidities and assessment of physiologic age instead of chronologic age. Optimization of these comorbidities is key to sustaining favorable outcomes in microsurgical free flap reconstruction in the elderly population.
老年人口不断增加,使得越来越多的老年患者需要进行涉及游离组织移植的复杂重建手术。本研究的目的是利用一个全国性多机构数据库评估老年患者显微外科游离组织移植的安全性、有效性和结果。
我们对美国外科医师学会国家外科质量改进计划(ACS NSQIP)数据库进行了回顾性分析,以确定接受游离组织移植的患者。我们根据年龄将队列分为18 - 49岁、50 - 59岁、60 - 69岁、70 - 79岁和80岁及以上,并分析手术并发症、医疗并发症、死亡率和皮瓣失败等主要结果。
共确定5951例患者纳入分析。单因素分析显示,随着年龄增长,手术(P = 0.001)和医疗(P < 0.001)并发症发生率逐渐增加。在控制混杂变量后,年龄与手术(比值比[OR] 1.00,95%置信区间[CI] 0.99 - 1.01,P = 0.737)或医疗(OR 1.01,95% CI 0.99 - 1.03,P = 0.209)并发症、皮瓣失败(OR 1.00,95% CI 1.00 - 1.02,P = 0.689)或再次手术(OR 1.01,95% CI 1.00 - 1.03,P = 0.165)的发生率均无显著相关性。与手术并发症相关的因素包括体重指数(BMI)(OR 1.03,95% CI 1.00 - 1.05,P = 0.031)、手术时间延长(OR 1.001,95% CI 1.000 - 1.002,P = 0.002)、美国麻醉医师协会(ASA)分级为3级或更高(OR 1.62,95% CI 1.17 - 2.23,P = 0.003)以及住院时间延长(OR 1.03,95% CI 1.02 - 1.04,P < 0.001)。ASA分级为3级或更高(OR 2.57,95% CI 1.48 - 4.45,P = 0.001)、肾脏病史(OR 10.13,95% CI 1.57 - 65.55,P = 0.015)和住院时间延长(OR 1.06,95% CI 1.04 - 1.08,P < 0.001)与医疗并发症相关。年龄与死亡率增加相关(OR 1.06,95% CI 1.00 - 1.13,P = 0.048)。
在患者评估中,不应仅将年龄作为绝对甚至相对的禁忌证。相反,术前评估应侧重于合并症和生理年龄评估,而非实际年龄。优化这些合并症是老年人群显微外科游离皮瓣重建维持良好结果的关键。